Skip to main content

Articles

Original Research
The Relative Burden of Menopausal and Postmenopausal Symptoms versus Other Major Conditions: A Retrospective Analysis of the Medical Expenditure Panel Survey Data
Annlouise R. Assaf, PhD; Andrew G. Bushmakin, MS; Nina Joyce, PhD; Michael J. Louie, MD, MPH, MSc; Michael Flores, MPH; Margaret Moffatt, MPH
Stakeholder Perspective
Hormone Therapy Remains Effective for Treating Menopausal Symptoms, May Save Overall Costs
JoAnn V. Pinkerton, MD, FACOG, NCMP
Read More
Perspectives
Health Inequities in America
David B. Nash, MD, MBA
Read More
Original Research, Practice Management
Costs and Effectiveness of Mindfulness-Based Art Therapy versus Standard Breast Cancer Support Group for Women with Cancer
Katherine M. Prioli, BS; Laura T. Pizzi, PharmD, MPH; Kathryn M. Kash, PhD; Andrew B. Newberg, MD; Anna Marie Morlino, PharmD; Michael J. Matthews, BS; Daniel A. Monti, MD
Stakeholder Perspective
Creative Therapeutic Activities and Support Groups Benefit All Those Involved in Cancer Care
Linda Bily, MA, CSA, OPN-CG
Read More
Practice Management
Value-Based Perspectives on the Management of Allergic Rhinitis
Read More
Breast Cancer, Oncology
Abemaciclib, a New CDK4/CDK6 Inhibitor, Added to Fulvestrant Extends PFS in Advanced HR-Positive, HER2-Negative Breast Cancer
Read More
Lung Cancer, Oncology
Osimertinib Extends Progression-Free Survival in EGFR T790M–Positive Lung Cancer with CNS Metastases
Read More
Breast Cancer, Oncology
Olaparib First PARP Inhibitor to Show Advantage in BRCA-Positive Breast Cancer
Read More
Lung Cancer, Oncology
Alectinib New Standard of Care for ALK-Positive Non–Small-Cell Lung Cancer
Read More
Practice Management
Overcoming Barriers to Cost Transparency in Cancer Care
Read More
Practice Management
Novel Cancer Drugs Must Adopt Value-Based Pricing
Read More
Page 82 of 244
Results 811 - 820 of 2439